Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 45, Issue 5, 2006, Pages 482-494

  Hosoya, Noriko ^a,b   Sanada, Masashi ^a   Nannya, Yasuhito ^a   Nakazaki, Kumi ^a   Wang, Lili ^a   Hangaishi, Akira ^a   Kurokawa, Mineo ^a   Chiba, Shigeru ^a,b   Ogawa, Seishi ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BLAST CELL CRISIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CHROMOSOME 19P; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ADULT; AGED; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 33645822948     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20303     Document Type: Article

References (27)

1. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ. 1989. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86:6783-6787.
2. Albertson DG, Pinkel D. 2003. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12 Spec No 2:R145-R152.
3. Alimena G, De Cuia MR, Diverio D, Gastaldi R, Nanni M. 1987. The karyotype of blastic crisis. Cancer Genet Cytogenet 26:39-50.
4. Beck Z, Kiss A, Toth FD, Szabo J, Bacsi A, Balogh E, Borbely A, Telek B, Kovacs E, Olah E, Rak K. 2000. Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia. Leuk Lymphoma 38:587-597.
5. Blick M, Romero P, Talpaz M, Kurzrock R, Shtalrid M, Andersson B, Trujillo J, Beran M, Gutterman J. 1987. Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet Cytogenet 27:349-356.
6. Calabretta B, Perrotti D. 2004. The biology of CML blast crisis. Blood 103:4010-4022.
7. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berrebi A, Canaani E. 1991. p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88:6293-6297.
8. Fiegler H, Can P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361-374.
9. Fioretos T, Strombeck B, Sandberg T, Johansson B, Billstrom R, Borg A, Nilsson PG, Van Den Berghe H, Hagemeijer A, Mitelman F, Hoglund M. 1999. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 94:225-232.
10. Huret JL, Schoenwald M, Brizard A, Guilhot F, Vilmer E, Tanzer J. 1989. Chromosome 6p rearrangements appear to be secondary changes in various haematological malignancies. Leuk Res 13:819-824.
11. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. 2004. Detection of large-scale variation in the human genome. Nat Genet 36:949-951.
12. Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A, Rotter V. 1989. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 74:2318-2324.
13. LeMaistre A, Lee MS, Talpaz M, Kantarjian HM, Freireich EJ, Deisseroth AB, Trujillo JM, Stass SA. 1989. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia. Blood 73:889-891.
14. Melo JV, Hughes TP, Apperley JF. 2003. Chronic myeloid leukemia. Hematology (Am Soc Hematol Ed Prog):132-152.
15. Meza Espinoza JP, Judith Picos Cardenas V, Gutierrez-Angulo M, Gonzalez Garcia JR. 2004. Secondary chromosomal changes in 34 Philadelphia-chromosome- positive chronic myelocytic leukemia patients from the Mexican West. Cancer Genet Cytogenet 148:166-169.
16. Mitani K, Ogavva S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H. 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. Embo J 13:504-510.
17. Nakai H, Misawa S. 1995. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leuk Lymphoma 19:213-221.
18. Nakai H, Misawa S, Taniwaki M, Horiike S, Takashima T, Seriu T, Nakagawa H, Fujii H, Shimazaki C, Maruo N and others. 1994. Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia. Br J Haematol 87:425-427.
19. Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K. 1992. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res 52:6588-6593.
20. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Tovama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Copeland NG, Jenkins NA, Shaughnessy JD Jr. 1996. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 12:154-158.
21. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
22. Prigogina EL, Fleischman EW, Volkova MA, Frenkel MA. 1978. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia. Hum Genet 41:143-156.
23. Rowley JD. 1973. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
24. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M. Large-scale copy number polymorphism in the human genome. Science 305:525-528.
25. Sill H, Goldman JM, Cross NC. 1995. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85:2013-2016.
26. Wang L, Ogawa S, Hangaishi A, Qiao Y, Hosoya N, Nanya Y, Ohyashiki K, Mizoguchi H, Hirai H. 2003. Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10). Blood 102:2597-2604.
27. Yehuda O, Abeliovich D, Ben-Neriah S, Sverdlin I, Cohen R, Varadi G, Orr R, Ashkenazi YJ, Heyd J, Lugassy G, Ben Yehuda D. 1999. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive. Cancer Genet Cytogenet 114:100-107.